Vanguard Capital Management’s Tyra Biosciences TYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$38.7M Buy
1,768,140
+259,693
+17% +$7.14M ﹤0.01% 2036
2026
Q2
$48.2M Buy
1,508,447
+382,477
+34% +$12.7M ﹤0.01% 1970
2026
Q1
$43.1M Buy
+1,125,970
New +$36.5M ﹤0.01% 1931

Other funds holding TYRA

Vanguard Capital Management's TYRA Position: Q3 2026 in Review

Vanguard Capital Management increased its Tyra Biosciences (TYRA) stake by 17% in Q3 2026, buying an estimated $7.14M and bringing the position to 1,768,140 shares worth $38.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2036.

Vanguard Capital Management first reported a position in TYRA in Q1 2026 and has held it in 3 quarters since. The position peaked at $48.2M in Q2 2026. 155 funds tracked by Wall St. Rank hold TYRA as of Q3 2026.

  • Vanguard Capital Management held 1,768,140 shares of Tyra Biosciences worth $38.7M as of Q3 2026.
  • Vanguard Capital Management bought 259,693 Tyra Biosciences shares in Q3 2026, an estimated $7.14M.
  • Tyra Biosciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2036 holding.
  • Vanguard Capital Management first reported a position in Tyra Biosciences in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Tyra Biosciences position peaked at $48.2M in Q2 2026.
  • 155 funds tracked by Wall St. Rank held Tyra Biosciences as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.